Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
ThreatsDay Bulletin tracks active exploits, phishing waves, AI risks, major flaws, and cybercrime crackdowns shaping this week’s threat landscape.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results